Axsome Therapeutics, Inc. - Common Stock (AXSM)
CUSIP: 05464T104
Q4 2017 13F Holders as of 31 Dec 2017
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 48,932,355
- Total 13F shares
- 5,822,045
- Share change
- -187,046
- Total reported value
- $32,606,017
- Put/Call ratio
- 41%
- Price per share
- $5.60
- Number of holders
- 33
- Value change
- -$1,045,996
- Number of buys
- 14
- Number of sells
- 8
Quarterly Holders Quick Answers
What is CUSIP 05464T104?
CUSIP 05464T104 identifies AXSM - Axsome Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 05464T104:
Top shareholders of AXSM - Axsome Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
3.1%
|
1,516,212
|
$8,415,000 | — | 30 Sep 2017 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
3%
|
1,459,117
|
$8,026,000 | — | 30 Sep 2017 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
1.8%
|
881,000
|
$4,890,000 | — | 30 Sep 2017 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
1%
|
501,000
|
$2,781,000 | — | 30 Sep 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.86%
|
419,922
|
$2,331,000 | — | 30 Sep 2017 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.85%
|
415,279
|
$2,305,000 | — | 30 Sep 2017 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.35%
|
170,058
|
$944,000 | — | 30 Sep 2017 | |
| Opus Point Partners Management, LLC |
13F
|
Company |
0.27%
|
133,500
|
$741,000 | — | 30 Sep 2017 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.26%
|
125,670
|
$697,000 | — | 30 Sep 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.19%
|
94,205
|
$522,000 | — | 30 Sep 2017 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.1%
|
50,000
|
$278,000 | — | 30 Sep 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.09%
|
45,263
|
$251,000 | — | 30 Sep 2017 | |
| Mariner, LLC |
13F
|
Company |
0.08%
|
41,525
|
$230,000 | — | 30 Sep 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.07%
|
34,904
|
$194,000 | — | 30 Sep 2017 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.07%
|
33,600
|
$186,000 | — | 30 Sep 2017 | |
| BALDWIN WEALTH PARTNERS LLC/MA |
13F
|
Company |
0.04%
|
19,551
|
$109,000 | — | 30 Sep 2017 | |
| PVG ASSET MANAGEMENT CORP |
13F
|
Company |
0.04%
|
18,725
|
$103,923 | — | 30 Sep 2017 | |
| BARCLAYS PLC |
13F
|
Company |
0.04%
|
17,500
|
$97,000 | — | 30 Sep 2017 | |
| FORBES J M & CO LLP |
13F
|
Company |
0.03%
|
15,066
|
$83,000 | — | 30 Sep 2017 | |
| Sandy Spring Bank |
13F
|
Company |
0.02%
|
8,755
|
$49,000 | — | 30 Sep 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
4,010
|
$22,000 | — | 30 Sep 2017 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
2,000
|
$11,000 | — | 30 Sep 2017 | |
| Cable Hill Partners, LLC |
13F
|
Company |
0%
|
1,000
|
$6,000 | — | 30 Sep 2017 | |
| MEEDER ASSET MANAGEMENT INC |
13F
|
Company |
0%
|
835
|
$5,000 | — | 30 Sep 2017 | |
| LADENBURG THALMANN FINANCIAL SERVICES INC. |
13F
|
Company |
0%
|
391
|
$2,000 | — | 30 Sep 2017 | |
| UBS Group AG |
13F
|
Company |
0%
|
240
|
$1,000 | — | 30 Sep 2017 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
226
|
$1,000 | — | 30 Sep 2017 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
3
|
$17 | — | 30 Sep 2017 |
Institutional Holders of Axsome Therapeutics, Inc. - Common Stock (AXSM) as of Q4 2017
As of 31 Dec 2017,
Axsome Therapeutics, Inc. - Common Stock (AXSM) was held by
33 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,822,045 shares.
The largest 10 holders included
JPMORGAN CHASE & CO, FMR LLC, ROYCE & ASSOCIATES LP, Vanguard Group Inc, STIFEL FINANCIAL CORP, SPHERA FUNDS MANAGEMENT LTD., Opus Point Partners Management, LLC, MILLENNIUM MANAGEMENT LLC, Allianz Asset Management GmbH, and Alethea Capital Management, LLC.
This page lists
33
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2017 vs Q3 2017 Across Filers
Q3 2017 holders
26
Q4 2017 holders
33
Holder diff
7
| Investor | Q3 2017 Shares | Q4 2017 Shares | Share Diff | Share Chg % | Q3 2017 Value $ | Q4 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.